Nine Point Two Capital LLC Jazz Pharmaceuticals PLC Transaction History
Nine Point Two Capital LLC
- $252 Million
- Q4 2023
A detailed history of Nine Point Two Capital LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Nine Point Two Capital LLC holds 1,992 shares of JAZZ stock, worth $274,816. This represents 0.1% of its overall portfolio holdings.
Number of Shares
1,992
Previous 1,992
-0.0%
Holding current value
$274,816
Previous $257,000
4.67%
% of portfolio
0.1%
Previous 0.1%
Shares
1 transactions
Others Institutions Holding JAZZ
# of Institutions
544Shares Held
59MCall Options Held
125KPut Options Held
58.4K-
Black Rock Inc. New York, NY6.15MShares$848 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$833 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.53MShares$349 Million0.72% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$306 Million0.67% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.04MShares$281 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.65B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...